Table 1.
PTV_Eval V95%, % | Lung V20Gy, % | Heart , % Rx | Maximum Dose, % Rx | CI | ||
---|---|---|---|---|---|---|
Tangent test set | Clinical | 94.4 (3.5) | 12.9 (5.4) | 2.2 (1.4) | 108.7 (1.4) | 1.40 (0.16) |
Auto | 94.5 (2.7) | 9.8 (5.1) | 2.0 (1.0) | 109.1 (0.6) | 1.32 (0.10) | |
P value | 0.846 | 0.049a | 0.416 | 0.516 | 0.062 | |
SCV test set | Clinical | 82.6 (7.8) | 23.0 (8.6) | 2.4 (1.5) | 109.2 (2.9) | 1.43 (0.52) |
Auto | 87.5 (6.2) | 20.7 (8.0) | 2.7 (1.6) | 108.5 (1.4) | 1.45 (0.54) | |
P value | 0.037a | 0.232 | 0.049a | 0.316 | 0.977 | |
All test sets | Clinical | 88.5 (8.4) | 17.9 (8.7) | 2.3 (1.4) | 108.9 (2.2) | 1.41 (0.38) |
Auto | 91.0 (5.9) | 15.2 (8.6) | 2.4 (1.4) | 108.8 (1.1) | 1.38 (0.38) | |
P value | 0.079 | 0.025a | 0.466 | 0.727 | 0.239 |
Abbreviations: CI, conformity index; PTV, planning target volume; Rx, prescription dose; SCV, supraclavicular.
aIndicates statistical significance.